Postherpetic Neuralgia

• FDA label_change · 2025-12-29
  FDA Approved: PREGABALIN — Supplemental Application (Cipla USA, Inc.)

  FDA approved a supplemental application for Pregabalin submitted by Cipla USA, Inc., indicating changes to the drug's labeling. The notice d…

• FDA label_change · 2025-02-18
  FDA Approved: GABAPENTIN — Supplemental Application (American Health Packaging)

  FDA approved a supplemental application for Gabapentin (generic) submitted by American Health Packaging, indicating a labeling change for th…

• FDA label_change · 2024-12-31
  FDA Approved: GABAPENTIN — Supplemental Application (Laurus Labs Limited)

  FDA approved a supplemental application for gabapentin filed by Laurus Labs Limited, indicating a post-approval labeling change or related u…

• FDA label_change · 2017-03-06
  FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)

  FDA approved a supplemental application for Gralise (gabapentin) filed by Almatica Pharma LLC, resulting in a label change for the product.

• FDA label_change · 2013-01-31
  FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)

  FDA approved a supplemental application for GRALISE (gabapentin) submitted by Almatica Pharma LLC, resulting in updated labeling for the pro…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2012-12-14
  FDA Approved: QUTENZA — Supplemental Application (Averitas Pharma Inc)

  The FDA approved a supplemental application for QUTENZA (capsaicin) submitted by Averitas Pharma Inc, resulting in a labeling change for the…

• FDA label_change · 2012-11-30
  FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)

  FDA approved a supplemental application for GRALISE (gabapentin) filed by Almatica Pharma LLC, resulting in changes to the labeling.

• FDA label_change · 2011-08-29
  FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)

  FDA approved a Gabapentin supplemental application from Granules Pharmaceuticals Inc.

• FDA label_change · 2006-12-07
  FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)

  FDA approved a supplemental application for gabapentin—specifically a granule formulation—from Granules Pharmaceuticals Inc.